News - Page 76 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psychedelic Bulletin #125: New Data Boosts Spravato’s Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas

Psychedelic Bulletin #125: New Data Boosts Spravato’s Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas

Post published:December 4, 2022
Post category:Psychedelic Bulletin

Read more about the article Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Post published:December 2, 2022
Post category:Press Release

Read more about the article Psychedelic Research Bulletin: November 2022

Psychedelic Research Bulletin: November 2022

Post published:December 2, 2022
Post category:Psychedelics Research Review

Read more about the article Numinus Wellness Inc. Reports Q4 2022 and Annual Results

Numinus Wellness Inc. Reports Q4 2022 and Annual Results

Post published:December 2, 2022
Post category:Press Release

Read more about the article PsyBio Therapeutics Announces Non-Brokered Private Placement Financing

PsyBio Therapeutics Announces Non-Brokered Private Placement Financing

Post published:December 1, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES

FILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES

Post published:December 1, 2022
Post category:Press Release

Read more about the article Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine

Post published:December 1, 2022
Post category:Press Release

Read more about the article Revive Therapeutics Ltd. Announces Offering of Up to $5 Million

Revive Therapeutics Ltd. Announces Offering of Up to $5 Million

Post published:December 1, 2022
Post category:Press Release

Read more about the article Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

Post published:December 1, 2022
Post category:Press Release

Read more about the article Small Pharma to Participate in November Investor and Healthcare Conferences

Small Pharma to Participate in November Investor and Healthcare Conferences

Post published:November 29, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.